Doctor payments back on the table at GlaxoSmithKline with rollback of its total ban

As scrutiny over pharma payments to doctors and nurses makes headlines once again, GlaxoSmithKline is loosening the reins on its restrictive policy against those payments—the strictest in the industry—to allow some exceptions.